Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001711:Biotransformation; D002490:Central Nervous System / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006018:Glycols / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology* / Q000652:urine; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010243:Paralysis / Q000139:chemically induced; D011433:Propranolol / Q000378:metabolism / Q000494:pharmacology* / Q000652:urine; D012640:Seizures / Q000517:prevention & control; D013331:Strychnine / Q000037:antagonists & inhibitors; D013997:Time Factors
D000927:Anticonvulsants; D006018:Glycols; D011433:Propranolol; D013331:Strychnine